Mallinckrodt plc received approvals from the U.S. Bankruptcy Court for the District of Delaware for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on August 28, 2023.As expected, the Court granted Mallinckrodt...
Read Story
August 31, 2023, 07:55 AM
|
Mallinckrodt plc, a global specialty pharmaceutical company, has taken the next step to implement the comprehensive financial restructuring plan contemplated by a Restructuring Support Agreement ("RSA") the Company previously entered into with more...
Read Story
August 28, 2023, 07:48 AM
|
Mallinckrodt plc announced that it has voluntarily initiated Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware to modify its capital structure, including restructuring portions of its debt, and resolve several billion...
Read Story
October 12, 2020, 08:50 AM
|
Mallinckrodt plc announced that the Company and its specialty generics-focused subsidiaries Mallinckrodt LLC, SpecGx LLC and certain other affiliates (collectively, "Specialty Generics") have reached an agreement in principle on the terms of a global...
Read Story
February 26, 2020, 09:15 AM
|
Mallinckrodt has entered into a $600 million senior secured term loan facility to help finance its merger with Sucampo Pharmaceuticals, Inc., according to a regulatory filing. The New Term Loan is an incremental facility under the Credit Agreement...
Read Story
February 14, 2018, 07:15 AM
|